Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why All the Fury over Furin?
Essam Eldin A. Osman, Alnawaz Rehemtulla, Nouri Neamati
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2747-2784
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 309-309
Open Access | Times Cited: 17
Targeting furin, a cellular proprotein convertase, for COVID-19 prevention and therapeutics
Xia Jiang, Dabing Li, Mazaher Maghsoudloo, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104026-104026
Closed Access | Times Cited: 6
Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
Anja Kolarič, Marko Jukič, Urban Bren
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 165-165
Open Access | Times Cited: 26
Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
Manon Barthe, Leslie Hertereau, Noura Lamghari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6253-6253
Open Access | Times Cited: 14
The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2
Gary Thomas, Frédéric Couture, Anna Kwiatkowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3435-3435
Open Access | Times Cited: 19
How Electricity Prevents Us from Bleeding to Death
Colin D McCaig
Reviews of physiology, biochemistry and pharmacology (2025), pp. 115-145
Closed Access
SARS-CoV-2 Is an Electricity-Driven Virus
Colin D McCaig
Reviews of physiology, biochemistry and pharmacology (2025), pp. 361-410
Closed Access
Identification of Furin Protease Small-Molecule Inhibitor with a 1,3-Thiazol-2-ylaminosulfonyl Scaffold
Anja Kolarič, Vid Ravnik, Sara Štumpf, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 273-273
Open Access
Furin and COVID-19: Structure, Function and Chemoinformatic Analysis of Representative Active Site Inhibitors
Bruno O. Villoutreix, Iker Badiola, Abdel‐Majid Khatib
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 17
Identification of Endoplasmic Reticulum Stress-Related Genes in Acute Myocardial Infarction: A Bioinformatics Approach with Experimental Validation
Zhiqi Tang, Jiacong Nong, Xue Qiu, et al.
Biochemical Genetics (2025)
Closed Access
Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19
Bismark Dankwa, Emmanuel Broni, Kweku S. Enninful, et al.
Structural Chemistry (2022) Vol. 33, Iss. 6, pp. 2221-2241
Open Access | Times Cited: 16
Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence
Izabela Bolesławska, Magdalena Kowalówka, Natasza Bolesławska-Król, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1262-1262
Open Access | Times Cited: 8
W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics
Harry Ridgway, John D. Orbell, Minos‐Timotheos Matsoukas, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 4589-4612
Open Access | Times Cited: 8
Fragment‐Based Design, Synthesis, and Characterization of Aminoisoindole‐Derived Furin Inhibitors
Roman W. Lange, Konstantin Bloch, Miriam Ruth Heindl, et al.
ChemMedChem (2024) Vol. 19, Iss. 9
Open Access | Times Cited: 2
Aspergillus fumigatus secretes a protease(s) that displays in silico binding affinity towards the SARS-CoV-2 spike protein and mediates SARS-CoV-2 pseudovirion entry into HEK-293T cells
Nozethu Mjokane, Eric O. Akintemi, Saheed Sabiu, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood–Brain Barrier
Graham J. Moore, Harry Ridway, Laura Kate Gadanec, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5779-5779
Open Access | Times Cited: 2
Development and Prospects of Furin Inhibitors for Therapeutic Applications
Alexandre V. Ivachtchenko, Alexander Khvat, Dmitrii O. Shkil
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9199-9199
Open Access | Times Cited: 2
Analysis of the molecular determinants for furin cleavage of the spike protein S1/S2 site in defined strains of the prototype coronavirus murine hepatitis virus (MHV)
Annette Choi, Ekaterina D. Kots, Deanndria T. Singleton, et al.
Virus Research (2023) Vol. 340, pp. 199283-199283
Open Access | Times Cited: 6
Cyclic Peptidic Furin Inhibitors Developed by Combinatorial Chemistry
Agata Gitlin‐Domagalska, Dawid Dębowski, Aleksandra Maciejewska, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 458-465
Open Access | Times Cited: 4
Docking, MD Simulations, and DFT Calculations: Assessing W254’s Function and Sartan Binding in Furin
Nikitas Georgiou, Thomas Mavromoustakos, Demeter Tzeli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8226-8238
Open Access | Times Cited: 1
Evaluation of Potential Furin Protease Inhibitory Properties of Pioglitazone, Rosiglitazone, and Pirfenidone: An In Silico Docking and Molecular Dynamics Simulation Approach
Ahtziri Socorro Carranza-Aranda, Carlos Daniel Díaz-Palomera, Eduardo Lepe-Reynoso, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8665-8684
Open Access | Times Cited: 1
Advances Toward COVID-19 Therapies Special Issue
Nouri Neamati
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 2713-2715
Closed Access | Times Cited: 7
The Role of Furin and Its Therapeutic Potential in Cardiovascular Disease Risk
Hannah Fry, Mohsen Mazidi, Christiana Kartsonaki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9237-9237
Open Access | Times Cited: 1
Permethrin as a Potential Furin Inhibitor through a Novel Non-Competitive Allosteric Inhibition
Dongyan Feng, Le Ren, Jiaqi Wu, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1883-1883
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top